{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:06:56Z","timestamp":1776096416459,"version":"3.50.1"},"reference-count":90,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Cerebral cavernous malformations (CCMs) are groups of blood vessels that develop abnormally in both the brain and\/or spinal cord. Currently, MRI and\/or CT are the primary methods for assessing CCMs. Plasma-based biomarkers could serve as a complement to standard imaging techniques by providing a quantitative and molecular-based technique to detect disease at lower cost. Therefore, the authors evaluated cell division cycle 42 binding protein beta (CDC42BPB) as a potential novel plasma biomarker for CCMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Plasma samples were obtained from patients with pathological analysis\u2013confirmed CCM (n = 10, age 1\u201316 years) and compared to controls (n = 24, age 1\u201319 years). The protein levels were measured using the Olink Proximity Extension Assay. Findings were confirmed with ELISA. CDC42BPB expression was further analyzed with Western blot and immunohistochemistry analysis in patient-derived primary cells and CCM tissues, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>CCM patients exhibited significantly higher CDC42BPB plasma levels compared to controls (approximately 6-fold greater expression, p = 0.004). Furthermore, the high CDC42BPB plasma expression was concordant with the protein levels in CCM tissues and patient-derived primary cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The authors present data supporting the measurement of CDC42BPB plasma level as a putative biomarker for CCMs. These findings have implications relevant to improving diagnosis, follow-up, and molecular pathophysiological analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.9.peds25375","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:18:09Z","timestamp":1769825889000},"page":"352-359","source":"Crossref","is-referenced-by-count":0,"title":["Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformations"],"prefix":"10.3171","volume":"37","author":[{"given":"Yousef","family":"Hattar","sequence":"first","affiliation":[{"name":"Vascular Biology Program, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Sesen","sequence":"additional","affiliation":[{"name":"Vascular Biology Program, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyra","family":"Martinez","sequence":"additional","affiliation":[{"name":"Vascular Biology Program, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Ashok","sequence":"additional","affiliation":[{"name":"Vascular Biology Program, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Lupieri","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Shan","family":"Lang","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Children\u2019s Hospital of Philadelphia;"},{"name":"Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory G.","family":"Heuer","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Children\u2019s Hospital of Philadelphia;"},{"name":"Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Tucker","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Children\u2019s Hospital of Philadelphia;"},{"name":"Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Vascular Biology Program, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"},{"name":"Department of Surgery, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"},{"name":"Department of Neurosurgery, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aram","family":"Ghalali","sequence":"additional","affiliation":[{"name":"Vascular Biology Program, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"},{"name":"Department of Surgery, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"11","key":"b1","series-title":"N Engl J Med","first-page":"1022","article-title":"Cavernous malformations of the central nervous system","volume":"390","author":"Smith ER","year":"2024","unstructured":"Smith ER. Cavernous malformations of the central nervous system. N Engl J Med. 2024;390(11):1022\u20131028."},{"issue":"5","key":"b2","series-title":"Neurosurgery","first-page":"665","article-title":"Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel","volume":"80","author":"Akers A","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, A Awad I,  Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017;80(5):665\u2013680."},{"issue":"14","key":"b3","series-title":"Cancer Res","first-page":"3716","article-title":"Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma","volume":"74","author":"Akino T","year":"2014","unstructured":"Akino T, Han X, Nakayama H,  Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res. 2014;74(14):3716\u20133726."},{"key":"b4","series-title":"Front Neurosci","first-page":"1442110","article-title":"Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment","volume":"18","author":"Ashok K","year":"2024","unstructured":"Ashok K, Martinez T, Sesen J,  Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment. Front Neurosci. 2024;18:1442110."},{"issue":"1","key":"b5","series-title":"Sci Rep","first-page":"19244","article-title":"Disease specific urinary biomarkers in the central nervous system","volume":"13","author":"Duggins-Warf M","year":"2023","unstructured":"Duggins-Warf M, Ghalali A, Sesen J,  Disease specific urinary biomarkers in the central nervous system. Sci Rep. 2023;13(1):19244."},{"issue":"4","key":"b6","series-title":"Exp Mol Med","first-page":"658","article-title":"Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients","volume":"52","author":"Fehnel KP","year":"2020","unstructured":"Fehnel KP, Penn DL, Duggins-Warf M,  Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients. Exp Mol Med. 2020;52(4):658\u2013671."},{"issue":"3","key":"b7","series-title":"J Neurosurg Pediatr","first-page":"228","article-title":"Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics","volume":"31","author":"Kahle KT","year":"2023","unstructured":"Kahle KT, Duran D, Smith ER. Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics. J Neurosurg Pediatr. 2023;31(3):228\u2013237."},{"issue":"4","key":"b8","series-title":"J Neurosurg Pediatr","first-page":"396","article-title":"Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature","volume":"18","author":"Pricola Fehnel K","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, Zurakowski D,  Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Pediatr. 2016;18(4):396\u2013407."},{"key":"b9","series-title":"Front Neurol","first-page":"661952","article-title":"Non-invasive urinary biomarkers in moyamoya disease","volume":"12","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER. Non-invasive urinary biomarkers in moyamoya disease. Front Neurol. 2021;12:661952."},{"key":"b10","series-title":"Brain Res","first-page":"147348","article-title":"Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion","volume":"1762","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Shah N,  Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion. Brain Res. 2021;1762:147348."},{"issue":"1","key":"b11","series-title":"Cell Mol Neurobiol","first-page":"12","article-title":"Discovery and characterization of Ephrin B2 and EphB4 dysregulation and novel mutations in cerebral cavernous malformations: in vitro and patient-derived evidence of ephrin-mediated endothelial cell pathophysiology","volume":"44","author":"Sesen J","year":"2023","unstructured":"Sesen J, Ghalali A, Driscoll J,  Discovery and characterization of Ephrin B2 and EphB4 dysregulation and novel mutations in cerebral cavernous malformations: in vitro and patient-derived evidence of ephrin-mediated endothelial cell pathophysiology. Cell Mol Neurobiol. 2023;44(1):12."},{"issue":"6","key":"b12","series-title":"J Korean Neurosurg Soc","first-page":"415","article-title":"Moyamoya biomarkers","volume":"57","author":"Smith ER","year":"2015","unstructured":"Smith ER. Moyamoya biomarkers. J Korean Neurosurg Soc. 2015;57(6):415\u2013421."},{"issue":"3","key":"b13","series-title":"Neurosurg Clin N Am","first-page":"483","article-title":"Cavernous malformations","volume":"21","author":"Smith ER","year":"2010","unstructured":"Smith ER, Scott RM. Cavernous malformations. Neurosurg Clin N Am. 2010;21(3):483\u2013490."},{"issue":"8","key":"b14","series-title":"Clin Cancer Res","first-page":"2378","article-title":"Urinary biomarkers predict brain tumor presence and response to therapy","volume":"14","author":"Smith ER","year":"2008","unstructured":"Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008;14(8):2378\u20132386."},{"issue":"12","key":"b15","series-title":"Circ Res","first-page":"1716","article-title":"Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth","volume":"122","author":"Girard R","year":"2018","unstructured":"Girard R, Zeineddine HA, Koskim\u00e4ki J,  Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth. Circ Res. 2018;122(12):1716\u20131721."},{"key":"b16","series-title":"EBioMedicine","first-page":"104914","article-title":"Circulating biomarkers in familial cerebral cavernous malformation","volume":"99","author":"Lazzaroni F","year":"2024","unstructured":"Lazzaroni F, Meessen JMTA, Sun Y,  Circulating biomarkers in familial cerebral cavernous malformation. EBioMedicine. 2024;99:104914."},{"issue":"1","key":"b17","series-title":"Sci Rep","first-page":"11284","article-title":"Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study","volume":"15","author":"Li C","year":"2025","unstructured":"Li C, Huang S, Li Q,  Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study. Sci Rep. 2025;15(1):11284."},{"issue":"5","key":"b18","series-title":"Biochim Biophys Acta Mol Basis Dis","first-page":"167139","article-title":"Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology","volume":"1870","author":"Jauhiainen S","year":"2024","unstructured":"Jauhiainen S, Onyeogaziri FC, Lazzaroni F,  Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5):167139."},{"issue":"4","key":"b19","series-title":"PLoS One","first-page":"e95192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson E","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G,  Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9(4):e95192."},{"key":"b20","article-title":"OlinkRPackage. GitHub","author":"Nevola K","unstructured":"Nevola K, Guess J, Forsberg S,  OlinkRPackage. GitHub. Accessed October 23, 2025. https:\/\/github.com\/Olink-Proteomics\/OlinkRPackage"},{"key":"b21","series-title":"Updated February","article-title":"Olink Proteomics","volume":"24,","author":"Olink\u00ae Analyze Vignette","year":"2025","unstructured":"Olink\u00ae Analyze Vignette. Olink Proteomics. Updated February 24,2025. Accessed October 23, 2025. https:\/\/cran.r-project.org\/web\/packages\/OlinkAnalyze\/vignettes\/Vignett.html#contact-us"},{"key":"b22","series-title":"BMJ","first-page":"b3016","article-title":"Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"339","author":"Morris Z","year":"2009","unstructured":"Morris Z, Whiteley WN, Longstreth WT,  Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016."},{"issue":"5","key":"b23","series-title":"J Neurosurg","first-page":"1188","article-title":"Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort","volume":"120","author":"Moore SA","year":"2014","unstructured":"Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg. 2014;120(5):1188\u20131192."},{"issue":"9","key":"b24","series-title":"Radiol Med","first-page":"695","article-title":"Is MRI imaging in pediatric age totally safe? A critical reprisal","volume":"123","author":"Salerno S","year":"2018","unstructured":"Salerno S, Granata C, Trapenese M,  Is MRI imaging in pediatric age totally safe? A critical reprisal. Radiol Med. 2018;123(9):695\u2013702."},{"issue":"11","key":"b25","series-title":"Pediatr Radiol","first-page":"1353","article-title":"Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives?","volume":"41","author":"Edwards AD","year":"2011","unstructured":"Edwards AD, Arthurs OJ. Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives?. Pediatr Radiol. 2011;41(11):1353\u20131364."},{"issue":"4","key":"b26","series-title":"Neurosurg Clin N Am","first-page":"449","article-title":"Cavernous malformations: updates in surgical management and biology","volume":"33","author":"Dammann P","year":"2022","unstructured":"Dammann P, Santos AN, Wan XY, Zhu Y, Sure U. Cavernous malformations: updates in surgical management and biology. Neurosurg Clin N Am. 2022;33(4):449\u2013460."},{"issue":"1","key":"b27","series-title":"Commun Med (Lond)","first-page":"35","article-title":"Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma","volume":"3","author":"Srinath A","year":"2023","unstructured":"Srinath A, Xie B, Li Y,  Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma. Commun Med (Lond). 2023;3(1):35."},{"key":"b28","series-title":"Front Mol Neurosci","first-page":"1185021","article-title":"Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder","volume":"16","author":"Bao XH","year":"2023","unstructured":"Bao XH, Chen BF, Liu J,  Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder. Front Mol Neurosci. 2023;16:1185021."},{"issue":"5","key":"b29","series-title":"Am J Alzheimers Dis Other Demen","first-page":"290","article-title":"Plasma biomarkers: potent screeners of Alzheimer\u2019s disease","volume":"34","author":"Naveed M","year":"2019","unstructured":"Naveed M, Mubeen S, Khan A, Ibrahim S, Meer B. Plasma biomarkers: potent screeners of Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 2019;34(5):290\u2013301."},{"issue":"1","key":"b30","series-title":"Cardiovasc Diabetol","first-page":"140","article-title":"Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases","volume":"18","author":"Lorenzo-Almor\u00f3s A","year":"2019","unstructured":"Lorenzo-Almor\u00f3s A, Hang T, Peir\u00f3 C,  Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):140."},{"key":"b31","series-title":"Clin Chim Acta","first-page":"117798","article-title":"Urinary biomarkers in kidney disease","volume":"555","author":"Canki E","year":"2024","unstructured":"Canki E, Kho E, Hoenderop JGJ. Urinary biomarkers in kidney disease. Clin Chim Acta. 2024;555:117798."},{"issue":"1","key":"b32","series-title":"J Exp Clin Cancer Res","first-page":"56","article-title":"AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype","volume":"44","author":"Sesen J","year":"2025","unstructured":"Sesen J, Martinez T, Busatto S,  AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype. J Exp Clin Cancer Res. 2025;44(1):56."},{"issue":"10","key":"b33","series-title":"J Neurointerv Surg","first-page":"1089","article-title":"Rupture risk assessment in cerebral arteriovenous malformations: an ensemble model using hemodynamic and morphological features","volume":"17","author":"Zhu H","year":"2025","unstructured":"Zhu H, Liu L, Liang S,  Rupture risk assessment in cerebral arteriovenous malformations: an ensemble model using hemodynamic and morphological features. J Neurointerv Surg. 2025;17(10):1089\u20131095."},{"issue":"4","key":"b34","series-title":"Neurogenetics","first-page":"249","article-title":"CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations","volume":"8","author":"Voss K","year":"2007","unstructured":"Voss K, Stahl S, Schleider E,  CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics. 2007;8(4):249\u2013256."},{"issue":"11","key":"b35","series-title":"Open Biol","first-page":"200263","article-title":"Signalling through cerebral cavernous malformation protein networks","volume":"10","author":"Su VL","year":"2020","unstructured":"Su VL, Calderwood DA. Signalling through cerebral cavernous malformation protein networks. Open Biol. 2020;10(11):200263."},{"key":"b36","series-title":"Nat Commun","first-page":"6:6449","article-title":"CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling","volume":"6","author":"Lant B","year":"2015","unstructured":"Lant B, Yu B, Goudreault M,  CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling. Nat Commun. 2015;6:6:6449."},{"issue":"8","key":"b37","series-title":"Circ Res","first-page":"1240","article-title":"CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression","volume":"124","author":"Castro M","year":"2019","unstructured":"Castro M, Lavi\u00f1a B, Ando K,  CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression. Circ Res. 2019;124(8):1240\u20131252."},{"issue":"5","key":"b38","series-title":"Trends Cell Biol","first-page":"230","article-title":"Bidirectional Eph-ephrin signaling during axon guidance","volume":"17","author":"Egea J","year":"2007","unstructured":"Egea J, Klein R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol. 2007;17(5):230\u2013238."},{"issue":"Pt 12","key":"b39","series-title":"J Cell Sci","first-page":"2461","article-title":"Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells","volume":"116","author":"F\u00fcller T","year":"2003","unstructured":"F\u00fcller T, Korff T, Kilian A, Dandekar G, Augustin HG. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci. 2003;116(Pt 12):2461\u20132470."},{"issue":"19","key":"b40","series-title":"Blood","first-page":"4565","article-title":"Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth","volume":"119","author":"Ab\u00e9ngozar MA","year":"2012","unstructured":"Ab\u00e9ngozar MA, de Frutos S, Ferreiro S,  Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood. 2012;119(19):4565\u20134576."},{"issue":"11","key":"b41","series-title":"Nat Neurosci","first-page":"1117","article-title":"EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP","volume":"5","author":"Irie F","year":"2002","unstructured":"Irie F, Yamaguchi Y. EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP. Nat Neurosci. 2002;5(11):1117\u20131118."},{"issue":"2","key":"b42","series-title":"Small GTPases","first-page":"81","article-title":"Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1","volume":"6","author":"Zhao Z","year":"2015","unstructured":"Zhao Z, Manser E. Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1. Small GTPases. 2015;6(2):81\u201388."},{"issue":"4","key":"b43","series-title":"Angiogenesis","first-page":"523","article-title":"FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2","volume":"26","author":"Tsuji-Tamura K","year":"2023","unstructured":"Tsuji-Tamura K, Ogawa M. FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2. Angiogenesis. 2023;26(4):523\u2013545."},{"issue":"9","key":"b44","series-title":"J Cell Mol Med","first-page":"1848","article-title":"EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation","volume":"21","author":"You C","year":"2017","unstructured":"You C, Zhao K, Dammann P,  EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation. J Cell Mol Med. 2017;21(9):1848\u20131858."},{"issue":"3","key":"b45","series-title":"Nat Rev Drug Discov","first-page":"167","article-title":"CDC42BPA\/MRCK\u03b1: a kinase target for brain, ovarian and skin cancers","volume":"20","author":"East MP","year":"2021","unstructured":"East MP, Asquith CRM. CDC42BPA\/MRCK\u03b1: a kinase target for brain, ovarian and skin cancers. Nat Rev Drug Discov. 2021;20(3):167."},{"issue":"11","key":"b1","series-title":"N Engl J Med","first-page":"1022","article-title":"Cavernous malformations of the central nervous system","volume":"390","author":"Smith ER","year":"2024","unstructured":"Smith ER. Cavernous malformations of the central nervous system. N Engl J Med. 2024;390(11):1022\u20131028."},{"issue":"5","key":"b2","series-title":"Neurosurgery","first-page":"665","article-title":"Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel","volume":"80","author":"Akers A","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, A Awad I,  Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017;80(5):665\u2013680."},{"issue":"14","key":"b3","series-title":"Cancer Res","first-page":"3716","article-title":"Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma","volume":"74","author":"Akino T","year":"2014","unstructured":"Akino T, Han X, Nakayama H,  Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res. 2014;74(14):3716\u20133726."},{"key":"b4","series-title":"Front Neurosci","first-page":"1442110","article-title":"Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment","volume":"18","author":"Ashok K","year":"2024","unstructured":"Ashok K, Martinez T, Sesen J,  Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment. Front Neurosci. 2024;18:1442110."},{"issue":"1","key":"b5","series-title":"Sci Rep","first-page":"19244","article-title":"Disease specific urinary biomarkers in the central nervous system","volume":"13","author":"Duggins-Warf M","year":"2023","unstructured":"Duggins-Warf M, Ghalali A, Sesen J,  Disease specific urinary biomarkers in the central nervous system. Sci Rep. 2023;13(1):19244."},{"issue":"4","key":"b6","series-title":"Exp Mol Med","first-page":"658","article-title":"Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients","volume":"52","author":"Fehnel KP","year":"2020","unstructured":"Fehnel KP, Penn DL, Duggins-Warf M,  Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients. Exp Mol Med. 2020;52(4):658\u2013671."},{"issue":"3","key":"b7","series-title":"J Neurosurg Pediatr","first-page":"228","article-title":"Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics","volume":"31","author":"Kahle KT","year":"2023","unstructured":"Kahle KT, Duran D, Smith ER. Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics. J Neurosurg Pediatr. 2023;31(3):228\u2013237."},{"issue":"4","key":"b8","series-title":"J Neurosurg Pediatr","first-page":"396","article-title":"Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature","volume":"18","author":"Pricola Fehnel K","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, Zurakowski D,  Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Pediatr. 2016;18(4):396\u2013407."},{"key":"b9","series-title":"Front Neurol","first-page":"661952","article-title":"Non-invasive urinary biomarkers in moyamoya disease","volume":"12","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER. Non-invasive urinary biomarkers in moyamoya disease. Front Neurol. 2021;12:661952."},{"key":"b10","series-title":"Brain Res","first-page":"147348","article-title":"Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion","volume":"1762","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Shah N,  Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion. Brain Res. 2021;1762:147348."},{"issue":"1","key":"b11","series-title":"Cell Mol Neurobiol","first-page":"12","article-title":"Discovery and characterization of Ephrin B2 and EphB4 dysregulation and novel mutations in cerebral cavernous malformations: in vitro and patient-derived evidence of ephrin-mediated endothelial cell pathophysiology","volume":"44","author":"Sesen J","year":"2023","unstructured":"Sesen J, Ghalali A, Driscoll J,  Discovery and characterization of Ephrin B2 and EphB4 dysregulation and novel mutations in cerebral cavernous malformations: in vitro and patient-derived evidence of ephrin-mediated endothelial cell pathophysiology. Cell Mol Neurobiol. 2023;44(1):12."},{"issue":"6","key":"b12","series-title":"J Korean Neurosurg Soc","first-page":"415","article-title":"Moyamoya biomarkers","volume":"57","author":"Smith ER","year":"2015","unstructured":"Smith ER. Moyamoya biomarkers. J Korean Neurosurg Soc. 2015;57(6):415\u2013421."},{"issue":"3","key":"b13","series-title":"Neurosurg Clin N Am","first-page":"483","article-title":"Cavernous malformations","volume":"21","author":"Smith ER","year":"2010","unstructured":"Smith ER, Scott RM. Cavernous malformations. Neurosurg Clin N Am. 2010;21(3):483\u2013490."},{"issue":"8","key":"b14","series-title":"Clin Cancer Res","first-page":"2378","article-title":"Urinary biomarkers predict brain tumor presence and response to therapy","volume":"14","author":"Smith ER","year":"2008","unstructured":"Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008;14(8):2378\u20132386."},{"issue":"12","key":"b15","series-title":"Circ Res","first-page":"1716","article-title":"Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth","volume":"122","author":"Girard R","year":"2018","unstructured":"Girard R, Zeineddine HA, Koskim\u00e4ki J,  Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth. Circ Res. 2018;122(12):1716\u20131721."},{"key":"b16","series-title":"EBioMedicine","first-page":"104914","article-title":"Circulating biomarkers in familial cerebral cavernous malformation","volume":"99","author":"Lazzaroni F","year":"2024","unstructured":"Lazzaroni F, Meessen JMTA, Sun Y,  Circulating biomarkers in familial cerebral cavernous malformation. EBioMedicine. 2024;99:104914."},{"issue":"1","key":"b17","series-title":"Sci Rep","first-page":"11284","article-title":"Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study","volume":"15","author":"Li C","year":"2025","unstructured":"Li C, Huang S, Li Q,  Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study. Sci Rep. 2025;15(1):11284."},{"issue":"5","key":"b18","series-title":"Biochim Biophys Acta Mol Basis Dis","first-page":"167139","article-title":"Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology","volume":"1870","author":"Jauhiainen S","year":"2024","unstructured":"Jauhiainen S, Onyeogaziri FC, Lazzaroni F,  Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5):167139."},{"issue":"4","key":"b19","series-title":"PLoS One","first-page":"e95192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson E","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G,  Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9(4):e95192."},{"key":"b20","article-title":"OlinkRPackage. GitHub","author":"Nevola K","unstructured":"Nevola K, Guess J, Forsberg S,  OlinkRPackage. GitHub. Accessed October 23, 2025. https:\/\/github.com\/Olink-Proteomics\/OlinkRPackage"},{"key":"b21","series-title":"Updated February","article-title":"Olink Proteomics","volume":"24,","author":"Olink\u00ae Analyze Vignette","year":"2025","unstructured":"Olink\u00ae Analyze Vignette. Olink Proteomics. Updated February 24,2025. Accessed October 23, 2025. https:\/\/cran.r-project.org\/web\/packages\/OlinkAnalyze\/vignettes\/Vignett.html#contact-us"},{"key":"b22","series-title":"BMJ","first-page":"b3016","article-title":"Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"339","author":"Morris Z","year":"2009","unstructured":"Morris Z, Whiteley WN, Longstreth WT,  Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016."},{"issue":"5","key":"b23","series-title":"J Neurosurg","first-page":"1188","article-title":"Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort","volume":"120","author":"Moore SA","year":"2014","unstructured":"Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg. 2014;120(5):1188\u20131192."},{"issue":"9","key":"b24","series-title":"Radiol Med","first-page":"695","article-title":"Is MRI imaging in pediatric age totally safe? A critical reprisal","volume":"123","author":"Salerno S","year":"2018","unstructured":"Salerno S, Granata C, Trapenese M,  Is MRI imaging in pediatric age totally safe? A critical reprisal. Radiol Med. 2018;123(9):695\u2013702."},{"issue":"11","key":"b25","series-title":"Pediatr Radiol","first-page":"1353","article-title":"Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives?","volume":"41","author":"Edwards AD","year":"2011","unstructured":"Edwards AD, Arthurs OJ. Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives?. Pediatr Radiol. 2011;41(11):1353\u20131364."},{"issue":"4","key":"b26","series-title":"Neurosurg Clin N Am","first-page":"449","article-title":"Cavernous malformations: updates in surgical management and biology","volume":"33","author":"Dammann P","year":"2022","unstructured":"Dammann P, Santos AN, Wan XY, Zhu Y, Sure U. Cavernous malformations: updates in surgical management and biology. Neurosurg Clin N Am. 2022;33(4):449\u2013460."},{"issue":"1","key":"b27","series-title":"Commun Med (Lond)","first-page":"35","article-title":"Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma","volume":"3","author":"Srinath A","year":"2023","unstructured":"Srinath A, Xie B, Li Y,  Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma. Commun Med (Lond). 2023;3(1):35."},{"key":"b28","series-title":"Front Mol Neurosci","first-page":"1185021","article-title":"Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder","volume":"16","author":"Bao XH","year":"2023","unstructured":"Bao XH, Chen BF, Liu J,  Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder. Front Mol Neurosci. 2023;16:1185021."},{"issue":"5","key":"b29","series-title":"Am J Alzheimers Dis Other Demen","first-page":"290","article-title":"Plasma biomarkers: potent screeners of Alzheimer\u2019s disease","volume":"34","author":"Naveed M","year":"2019","unstructured":"Naveed M, Mubeen S, Khan A, Ibrahim S, Meer B. Plasma biomarkers: potent screeners of Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 2019;34(5):290\u2013301."},{"issue":"1","key":"b30","series-title":"Cardiovasc Diabetol","first-page":"140","article-title":"Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases","volume":"18","author":"Lorenzo-Almor\u00f3s A","year":"2019","unstructured":"Lorenzo-Almor\u00f3s A, Hang T, Peir\u00f3 C,  Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):140."},{"key":"b31","series-title":"Clin Chim Acta","first-page":"117798","article-title":"Urinary biomarkers in kidney disease","volume":"555","author":"Canki E","year":"2024","unstructured":"Canki E, Kho E, Hoenderop JGJ. Urinary biomarkers in kidney disease. Clin Chim Acta. 2024;555:117798."},{"issue":"1","key":"b32","series-title":"J Exp Clin Cancer Res","first-page":"56","article-title":"AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype","volume":"44","author":"Sesen J","year":"2025","unstructured":"Sesen J, Martinez T, Busatto S,  AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype. J Exp Clin Cancer Res. 2025;44(1):56."},{"issue":"10","key":"b33","series-title":"J Neurointerv Surg","first-page":"1089","article-title":"Rupture risk assessment in cerebral arteriovenous malformations: an ensemble model using hemodynamic and morphological features","volume":"17","author":"Zhu H","year":"2025","unstructured":"Zhu H, Liu L, Liang S,  Rupture risk assessment in cerebral arteriovenous malformations: an ensemble model using hemodynamic and morphological features. J Neurointerv Surg. 2025;17(10):1089\u20131095."},{"issue":"4","key":"b34","series-title":"Neurogenetics","first-page":"249","article-title":"CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations","volume":"8","author":"Voss K","year":"2007","unstructured":"Voss K, Stahl S, Schleider E,  CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics. 2007;8(4):249\u2013256."},{"issue":"11","key":"b35","series-title":"Open Biol","first-page":"200263","article-title":"Signalling through cerebral cavernous malformation protein networks","volume":"10","author":"Su VL","year":"2020","unstructured":"Su VL, Calderwood DA. Signalling through cerebral cavernous malformation protein networks. Open Biol. 2020;10(11):200263."},{"key":"b36","series-title":"Nat Commun","first-page":"6:6449","article-title":"CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling","volume":"6","author":"Lant B","year":"2015","unstructured":"Lant B, Yu B, Goudreault M,  CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling. Nat Commun. 2015;6:6:6449."},{"issue":"8","key":"b37","series-title":"Circ Res","first-page":"1240","article-title":"CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression","volume":"124","author":"Castro M","year":"2019","unstructured":"Castro M, Lavi\u00f1a B, Ando K,  CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression. Circ Res. 2019;124(8):1240\u20131252."},{"issue":"5","key":"b38","series-title":"Trends Cell Biol","first-page":"230","article-title":"Bidirectional Eph-ephrin signaling during axon guidance","volume":"17","author":"Egea J","year":"2007","unstructured":"Egea J, Klein R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol. 2007;17(5):230\u2013238."},{"issue":"Pt 12","key":"b39","series-title":"J Cell Sci","first-page":"2461","article-title":"Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells","volume":"116","author":"F\u00fcller T","year":"2003","unstructured":"F\u00fcller T, Korff T, Kilian A, Dandekar G, Augustin HG. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci. 2003;116(Pt 12):2461\u20132470."},{"issue":"19","key":"b40","series-title":"Blood","first-page":"4565","article-title":"Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth","volume":"119","author":"Ab\u00e9ngozar MA","year":"2012","unstructured":"Ab\u00e9ngozar MA, de Frutos S, Ferreiro S,  Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood. 2012;119(19):4565\u20134576."},{"issue":"11","key":"b41","series-title":"Nat Neurosci","first-page":"1117","article-title":"EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP","volume":"5","author":"Irie F","year":"2002","unstructured":"Irie F, Yamaguchi Y. EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP. Nat Neurosci. 2002;5(11):1117\u20131118."},{"issue":"2","key":"b42","series-title":"Small GTPases","first-page":"81","article-title":"Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1","volume":"6","author":"Zhao Z","year":"2015","unstructured":"Zhao Z, Manser E. Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1. Small GTPases. 2015;6(2):81\u201388."},{"issue":"4","key":"b43","series-title":"Angiogenesis","first-page":"523","article-title":"FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2","volume":"26","author":"Tsuji-Tamura K","year":"2023","unstructured":"Tsuji-Tamura K, Ogawa M. FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2. Angiogenesis. 2023;26(4):523\u2013545."},{"issue":"9","key":"b44","series-title":"J Cell Mol Med","first-page":"1848","article-title":"EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation","volume":"21","author":"You C","year":"2017","unstructured":"You C, Zhao K, Dammann P,  EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation. J Cell Mol Med. 2017;21(9):1848\u20131858."},{"issue":"3","key":"b45","series-title":"Nat Rev Drug Discov","first-page":"167","article-title":"CDC42BPA\/MRCK\u03b1: a kinase target for brain, ovarian and skin cancers","volume":"20","author":"East MP","year":"2021","unstructured":"East MP, Asquith CRM. CDC42BPA\/MRCK\u03b1: a kinase target for brain, ovarian and skin cancers. Nat Rev Drug Discov. 2021;20(3):167."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/37\/4\/article-p352.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/37\/4\/article-p352.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/37\/4\/article-p352.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:26:25Z","timestamp":1776093985000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/37\/4\/article-p352.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":90,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2025.9.peds25375","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}